The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Of further importance is the presence of functional inactivation of the Rb protein in most human cancers (Sherr, 1996), an observation that suggests that this new therapeutic approach may be applicable to many malignancies.”
BackgroundAn Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., & Coen, D. M. (1991) · Science · doi:10.1126/science.1851332 · Cited by 1,050
Heise, C., Sampson-Johannes, A., Williams, A., Mccormick, F., Von Hoff, D. D., & Kirn, D. H. (1997) · Nature Medicine · doi:10.1038/nm0697-639 · Cited by 940
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., & Martuza, R. L. (1995) · Nature Medicine · doi:10.1038/nm0995-938 · Cited by 822
Suppression of the Neoplastic Phenotype by Replacement of the RB Gene in Human Cancer Cells
Huang, H.-J. S., Yee, J.-K., Shew, J.-Y., Chen, P.-L., Bookstein, R., Friedmann, T., Lee, E. Y.-H. P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3201247 · Cited by 812
Reovirus Therapy of Tumors with Activated Ras Pathway
Coffey, M. C., Strong, J. E., Forsyth, P. A., & Lee, P. W. K. (1998) · Science · doi:10.1126/science.282.5392.1332 · Cited by 750
Self-citationCellular targets for transformation by the adenovirus E1A proteins
Whyte, P., Williamson, N. M., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90984-7 · Cited by 729
Clonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
Roth, J. A., & Cristiano, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.21 · Cited by 635
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Barker, D., & Berk, A. J. (1987) · Virology · doi:10.1016/0042-6822(87)90441-7 · Cited by 385
Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., & zur Hausen, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9470-9478.1998 · Cited by 353
Freytag, S. O., Rogulski, K. R., Paielli, D. L., Gilbert, J. D., & Kim, J. H. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.9-1323 · Cited by 337
VIRAL TRANSACTIVATING PROTEINS
Flint, J., & Shenk, T. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.177 · Cited by 231
Two regions of the adenovirus early region 1A proteins are required for transformation
Whyte, P., Ruley, H. E., & Harlow, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.257-265.1988 · Cited by 226
The retinoblastoma gene is involved in malignant progression of astrocytomas
Henson, J. W., Schnitker, B. L., Correa, K. M., von Deimling, A., Fassbender, F., Xu, H., Benedict, W. F., Yandell, D. W., & Louis, D. N. (1994) · Annals of Neurology · doi:10.1002/ana.410360505 · Cited by 217
ONYX-015: Clinical data are encouraging
Kirn, D., Hermiston, T., & McCormick, F. (1998) · Nature Medicine · doi:10.1038/3902 · Cited by 203
Dietary iron and colorectal cancer risk
Nelson, R. L. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90010-e · Cited by 194
Puumalainen, A.-M., Vapalahti, M., Agrawal, R. S., Kossila, M., Laukkanen, J., Lehtolainen, P., Viita, H., Paljärvi, L., Vanninen, R., & Ylä-Herttuala, S. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.12-1769 · Cited by 193
Chase, M., Chung, R. Y., & Chiocca, E. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-444 · Cited by 178
Fueyo, J., Gomez-Manzano, C., Yung, W. K. A., Liu, T. J., Alemany, R., McDonnell, T. J., Shi, X., Rao, J. S., Levin, V. A., & Kyritsis, A. P. (1998) · Nature Medicine · doi:10.1038/nm0698-685 · Cited by 175
Self-citationCharacterization of p53 and p21 Functional Interactions in Glioma Cells en Route to Apoptosis
Gomez‐Manzano, C., Fueyo-Margareto, J., Kyritsis, A. P., Steck, P. A., Levin, V. A., Yung, W. K. A., & McDonnell, T. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.14.1036 · Cited by 142
Self-citationHay, J. G., Shapiro, N., Sauthoff, H., Heitner, S., Phupakdi, W., & Rom, W. N. (1999) · Human Gene Therapy · doi:10.1089/10430349950018652 · Cited by 69
The functional role of tumor suppressor genes in gliomas: Clues for future therapeutic strategies
Fueyo-Margareto, J., Gomez‐Manzano, C., Yung, W. K. A., & Kyritsis, A. P. (1998) · Neurology · doi:10.1212/wnl.51.5.1250 · Cited by 42
Self-citationComplementation of helper-dependent adenoviral vectors: size
Alemany, R., Dai, Y., Lou, Y. C., Sethi, E., Prokopenko, E., Josephs, S. F., & Zhang, W. (1997) · Journal of Virological Methods · doi:10.1016/s0166-0934(97)00129-8 · Cited by 39
Self-citationDifferential expression of myc, max and RB1 genes in human gliomas and glioma cell lines
Hirvonen, H., Salonen, R., Sandberg, M., VUORIO, E. I., Västrik, I., Kotilainen, E., & Kalimo, H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.3 · Cited by 37
Hamel, W., Westphal, M., & Shepard, H. M. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01324703 · Cited by 35
Cited by
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“An adenovirus expressing a mutant form of E1A that cannot bind RB should replicate selectively and kill cells lacking functional RB (Fueyo et al., 2000).”
BackgroundOncolytic viruses: a new class of immunotherapy drugs
Kaufman, H. L., Kohlhapp, F. J., & Zloza, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4663 · Cited by 1,642
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Lang, F. F., Conrad, C., Gomez-Manzano, C., Yung, W. K. A., Sawaya, R., Weinberg, J. S., Prabhu, S. S., Rao, G., Fuller, G. N., Aldape, K. D., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.8219 · Cited by 711
Self-citationOncolytic Viruses in Cancer Treatment: A Review
Lawler, S. E., Speranza, M.-C., Cho, C.-F., & Chiocca, E. A. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2064 · Cited by 592
Metadata
- Authors
- Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P. S., McDonnell, T. J., Mitlianga, P., Shi, Y.-X., Levin, V. A., Yung, W. K. A., & Kyritsis, A. P.
- Venue
- Oncogene
- Published
- 2000-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 2-12
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2110592777
- Cited by
- 764
- References
- 30
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.